Frontlight ResearchEarly access
Trial site
Steiermaerkische Krankenanstalten Ges.m.b.H.
- 10running trials
- 1closed trial
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Follicular lymphoma2 trials
- Multiple myeloma2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Hodgkin lymphoma1 trial
- Ovarian cancer1 trial
- Phase
- Phase 310 trials
- Phase 21 trial
- Status
- Recruiting7 trials
- Active, not recruiting3 trials
- Completed1 trial
- Lead sponsor
- AbbVie1 trial
- Celgene Corp.1 trial
- European Myeloma Network B.V.1 trial
- Kartos Therapeutics Inc.1 trial
- Lysarc1 trial
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
Recruiting
Recruiting
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Acute myeloid leukaemia1 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Follicular lymphoma1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026